← Назад к работе
Работы, на которые ссылается эта работа
Работ: 52
Работа: Genetic engineering in oncology based on CRISPR-Cas9 technology
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu, Zhenguo Zi, Yanling Jin +5
Статья2018Цитирований: 3ABIDelivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney +1
Обзорная статья2018Цитирований: 3ABIPhase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
Zhenguang Wang, Na Li, Kaichao Feng +14
Статья2021Цитирований: 3ABITGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors
Na Tang, Chen Cheng, Xingying Zhang +6
Статья2020Цитирований: 3ABINobel Prize 2020 in Chemistry honors CRISPR: a tool for rewriting the code of life
Lukas Westermann, Björn Neubauer, Michael Köttgen
Редакционная статья2020Цитирований: 2ABIThe Potential Revolution of Cancer Treatment with CRISPR Technology
Dimitrios Stefanoudakis, Nikhita Kathuria‐Prakash, Alexander W. Sun +10
Обзорная статья2023Цитирований: 2ABILatest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
Muhammad Naeem, Saman Majeed, Mubasher Zahir Hoque +1
Обзорная статья2020Цитирований: 2ABI